Communicable Diseases Agency designated as World Health Organization Collaborating Centre for Infection Prevention and Control
16 November 2026
The Communicable Diseases Agency (CDA) has been designated by the World Health Organization (WHO) as a WHO Collaborating Centre (CC) for Infection Prevention and Control (IPC), recognising Singapore's expertise and sustained efforts in strengthening infection prevention across its healthcare system. It is the first WHO CC dedicated to strengthening health systems through IPC.
The designation will enable Singapore to contribute its expertise to international IPC efforts while benefiting from closer collaboration with WHO and the global IPC community. Through the exchange of scientific evidence, expertise and practical experience, the partnership will support continued improvements in Singapore's IPC policies and practices, helping to protect patients and healthcare workers, reduce preventable infections and strengthen preparedness for future infectious disease threats.
CDA to Advance IPC in the Region
As a WHO CC, CDA will work closely with WHO, in particular its Member States in the Western Pacific Region1, to advance IPC through technical collaboration, capacity building, and the exchange of knowledge and best practices. This includes supporting countries in strengthening their national IPC programmes and healthcare-associated infection surveillance, contributing technical expertise to the development of international IPC guidelines, and building IPC capabilities across healthcare settings, including long-term care facilities.
Through closer collaboration with WHO and exchanges with international partners, CDA can also draw on international expertise and practical implementation experiences to inform the continued review and refinement of Singapore's IPC policies and practices.
“Infection prevention and control is essential for health systems to provide safe and effective care. As a WHO Collaborating Centre, CDA will bring Singapore’s considerable experience and expertise to support WHO’s global IPC priorities, while also contributing to progress in the Western Pacific Region. This partnership will strengthen our collective ability to support countries in integrating evidence-based and effective IPC in safer, more resilient health systems,” said Dr Sylvie Briand, WHO Chief Scientist and Assistant Director-General for Health Systems, Access and Data ad interim.
Adjunct Associate Professor Kalisvar Marimuthu, Head, WHO Collaborating Centre for Infection Prevention and Control at CDA, said, “IPC is fundamental to protecting patients and healthcare workers from preventable infections. This designation provides an opportunity for Singapore to share our expertise and experience internationally, while learning from global partners to strengthen IPC practices at home. Through collaboration and knowledge exchange, we can make healthcare safer for everyone.”
Partnering the Healthcare Sector to Strengthen IPC Capabilities in Singapore
CDA’s WHO CC designation builds on more than a decade of sustained national efforts in strengthening IPC across Singapore's healthcare system. Since its establishment in 2014, the National Infection Prevention and Control Committee (NIPC), comprising IPC experts from across Singapore's healthcare system, has played a key role in coordinating national IPC efforts. These include the development of national IPC guidelines and standards, surveillance of healthcare-associated infections, and strengthening IPC capabilities across healthcare and community settings.
Complementing these efforts is the National IPC Peer Review Programme, a key national initiative to strengthen IPC standards and practices across healthcare institutions. Introduced in 2018, the programme brings together multidisciplinary teams from different institutions, including IPC, facilities management, quality improvement and environmental services professionals, to share good practices and identify areas for improvement. Through cross-institutional learning and collaboration, the programme strengthens IPC capabilities, patient safety and outbreak preparedness across Singapore’s healthcare system.
These national initiatives, together with the sustained efforts of the healthcare institutions, IPC professionals, frontline healthcare workers and sector partners, have strengthened Singapore's IPC capabilities over the years.
As Singapore's population ages and healthcare is increasingly delivered across hospitals, community care and long-term care settings, CDA will continue to work with healthcare institutions and sector partners to strengthen IPC capabilities across the care continuum. This includes enhancing national surveillance, advancing evidence-based IPC practices, building workforce capabilities and strengthening outbreak preparedness and response. These efforts aim to reduce healthcare-associated infections, prevent outbreaks and safeguard patients and healthcare workers across healthcare and community settings.
COMMUNICABLE DISEASES AGENCY
16 NOVEMBER 2026
1 About the WHO Western Pacific Region: https://www.who.int/westernpacific/about/where-we-work (opens in new tab)
